Close

Advaxis (ADXS) Receives Patent Coverage in Japan for Lm-LLO Cancer Immunotherapy Platform Tech

July 28, 2014 7:43 AM EDT Send to a Friend
Advaxis (Nasdaq: ADXS) has received a notice of allowance from the Japan Patent Office for a patent application related to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login